Comments to FDA: PDUFA Share page: Docket Number: FDA-2010-N-0128 CHPA comments on proposed recommendations for the reauthorization of the Prescription Drug User Fee Act. Download Document Issues: OTC Medicines Monograph Reform Rx-to-OTC Switch User Fees Related Posts Press Releases and Statements CHPA Highlights Critical Importance of Consumer Healthcare, Warns of Unintended Consequences from Tariffs Feb 3, 2025 Press Releases and Statements CHPA Strengthens Regulatory Team with Two Accomplished Industry Experts Jan 31, 2025 Effectiveness of Phenylephrine as an Oral Decongestant